Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
“I felt I had a lot to give the world. Getting my first at university and doing so well in research was an antidote. Underneath, though, there is part of me that feels maybe one day someone will discover that I am stupid.” – Tony “Blue Peter” Hollander
“We all hype our work. We want to tell people our work is important. These patients, many of them coming to enroll in these trials, they have no other hope.” -Steven Houser, Hero of Research Ethics, Temple University
Macchiarini’s victim Paloma Cabeza speaks out again, fearing she doesn’t have much time left. She appeals to the Swedish prosecutor for justice in the deadly trachea transplant scandal.
Swedish prosecutor opened a criminal indictment against Paolo Macchiarini. The scandal surgeon will have to stand court trial for all 3 deadly plastic trachea transplants he performed at Karolinska.
Israeli scientists discovered a cure for coronavirus! Their proprietary PLX cells from placenta deliver 100% survival rate both against COVID-19 and a nuclear holocaust. The stocks soar.
In this 3rd instalment of her Celixir investigation, Patricia Murray learns whose side the British authority MHRA is on. Not the patients’, and certainly not on the side of facts.
Smut Clyde studies two Chinese research groups to understand how TCM can be used to create modern Photoshop art.
Catherine Verfaillie is a zombie scientist: her past stem cell research long discredited, but she still is an influential and very well funded star of Belgian science. Now Elisabeth Bik had a fresh new look at Verfaillie’s papers
Liverpool professor Patricia Murray continues investigating shady dealings of the regmed company Celixir, owned by struck-off dentist Ajan Reginald and Nobelist Sir Martin Evans
Patricia Murray uncovers the business secrets of the Nobelist Martin Evans and his partner Ajan Reginald. It seems the magic iMP cells used to treat patients in Greece were drawn from the blood of patients in Swansea, for the purpose of a secret PhD thesis. There is no serious science behind it, only serious investor money and a fraudulent patent.
